OncoInfluencers: Dialogue with Pasi Jänne, hosted by Gevorg Tamamyan

Join us for an exciting new episode of “OncoInfluencers,” hosted by Dr. Gevorg Tamamyan. In this episode, we have the honor of featuring Pasi Jänne, Senior Vice President for Translational Medicine and the Scientific Director of the Belfer Center for Applied Cancer Science, as well as the Director of Chen-Huang Center for EGFR Mutant Lung Cancers at Dana-Farber Cancer Institute.

In this episode of OncoInfluencers, Dr. Pasi A. Jänne talks about

• what was it like to study science in art school,
• his personal journey on becoming a doctor and choosing oncology as a specific field,
• the importance of having good mentors and guidance,
• future directions of oncology research and care, including potential game-changing technologies, evolving treatment paradigms, and efforts to improve outcomes for cancer patients worldwide and
• he offers his top three recommendations for places to visit in New York.

About Pasi Jänne

Dr. Pasi A. Jänne, MD, PhD, is a  leader in the field of thoracic oncology, renowned for his research and transformative clinical contributions. He received his MD and PhD from the University of Pennsylvania in 1996 and completed postgraduate training in internal medicine and medical oncology.

Currently, he is the Senior Vice President for Translational Medicine and the Scientific Director of the Belfer Center for Applied Cancer Science, as well as the Director of ChenHuang Center for EGFR Mutant Lung Cancers at Dana-Farber Cancer Institute. He is a Professor of Medicine at Harvard Medical School.

His main research interests include studying the therapeutic relevance of oncogenic alterations in lung cancer. He was one of the co-discoverers of epidermal growth factor receptor (EGFR) mutations and has led the development of therapeutic strategies for patients with EGFR mutant lung cancer.

Dr. Jänne’s pioneering efforts have not only shaped the landscape of lung cancer treatment but have also paved the way for numerous clinical trials and novel therapies, offering hope to patients worldwide.

He received numerous awards and distinctions among them Outstanding Investigator Award from the National Cancer Institute, Translational Research Award from the European Society for Medical Oncology and Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Research from American Association for Cancer, Merit Award from the American Society of Clinical Oncology and Medal of Honor from the American Cancer Society.

About Gevorg Tamamyan

The host, Dr. Gevorg Tamamyan is the Editor-in-chief of OncoDaily, Head of the Pediatric Cancer and Blood Disorders Center of Armenia, Chairman and Professor of the Department of Hematology and Pediatric Oncology at Yerevan State Medical University, CEO of the Immune Oncology Research Institute, President-Elect of the Pediatric Oncology East and Mediterranean (POEM) Group, Chairman of the Board of the Institute of Cancer and Crisis.

Dr. Tamamyan is the Past-Chair of the American Society of Clinical Oncology (ASCO) IDEA Steering Group and International Society of Pediatric Oncology (SIOP) PODC Supportive care WG, Ambassador of the Society of Hematologic Oncology.

He was selected for the ASCO Leadership Development Program and currently is a member of the ASCO International Committee. He is a recipient of numerous awards and distinctions, among them the ASCO IDEA and LIFe Awards, 40 under 40 in Cancer Award, he was recognized as a Young Leader of the International Agency for Cancer Research (IARC) and Union for International Cancer Control (UICC).

About OncoDaily

OncoDaily.com was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”.

Previous episodes of OncoInfluencers

Episode 1: OncoInfluencers: Dialogue with Françoise Meunier

Episode 2: OncoInfluencers: Dialogue with Dean Crowe

Episode 3: OncoInfluencers: Dialogue with Nagashree Seetharamu

Episode 4: OncoInfluencers: Dialogue with Julie Gralow

Episode 5: OncoInfluencers: Dialogue with Lillian L. Siu

Episode 6: OncoInfluencers: Dialogue with Douglas Flora